tradingkey.logo
搜索

Baxter International Inc

BAX
添加自选
21.550USD
+0.510+2.42%
收盘 06/25, 16:00美东报价延迟15分钟
11.13B总市值
亏损市盈率 TTM

关于 Baxter International Inc 公司

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Baxter International Inc简介

公司代码BAX
公司名称Baxter International Inc
上市日期Jun 20, 2097
CEOHider (Andrew P)
员工数量38000
证券类型Ordinary Share
年结日Jun 20
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编60015
电话12249482000
网址https://www.baxter.com/
公司代码BAX
上市日期Jun 20, 2097
CEOHider (Andrew P)

Baxter International Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%

常见问题

Baxter International Inc的前五大股东是谁?

Baxter International Inc 的前五大股东如下:Mr. Andrew P. Hider

有多少机构持有Baxter International Inc(BAX)的股份?

截至2026Q1,共有1767家机构持有Baxter International Inc的股份,合计持有的股份价值约为557.84M,占公司总股份的108.01%。与2025Q4相比,机构持股有所增加,增幅为-45350754.00。

哪个业务部门对Baxter International Inc的收入贡献最大?

在2026Q1,Infusion Therapies and Technologies业务部门对Baxter International Inc的收入贡献最大,创收4.10B,占总收入的36.47%。
KeyAI